Cinzia Cordioli

2.9k total citations · 1 hit paper
29 papers, 837 citations indexed

About

Cinzia Cordioli is a scholar working on Pathology and Forensic Medicine, Oncology and Neurology. According to data from OpenAlex, Cinzia Cordioli has authored 29 papers receiving a total of 837 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pathology and Forensic Medicine, 11 papers in Oncology and 7 papers in Neurology. Recurrent topics in Cinzia Cordioli's work include Multiple Sclerosis Research Studies (23 papers), Polyomavirus and related diseases (10 papers) and Peripheral Neuropathies and Disorders (5 papers). Cinzia Cordioli is often cited by papers focused on Multiple Sclerosis Research Studies (23 papers), Polyomavirus and related diseases (10 papers) and Peripheral Neuropathies and Disorders (5 papers). Cinzia Cordioli collaborates with scholars based in Italy, United States and Croatia. Cinzia Cordioli's co-authors include Nicola De Rossi, Ruggero Capra, Maria Pia Sormani, Francesco Patti, Sarah Rasia, Lucia Moiola, Paola Zaratin, Gioacchino Tedeschi, Paolo Immovilli and Irene Schiavetti and has published in prestigious journals such as Blood, PLoS ONE and Neurology.

In The Last Decade

Cinzia Cordioli

29 papers receiving 823 citations

Hit Papers

Disease‐Modifying Therapies and Coronavirus Disease 2019 ... 2021 2026 2022 2024 2021 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Disease‐Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis
    2021 296 citations Maria Pia Sormani, Nicola De Rossi et al. Annals of Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cinzia Cordioli Italy 16 591 338 315 206 145 29 837
Alexander Winkelmann Germany 15 585 1.0× 239 0.7× 193 0.6× 156 0.8× 164 1.1× 43 828
Zoé L. E. van Kempen Netherlands 13 350 0.6× 156 0.5× 152 0.5× 172 0.8× 94 0.6× 39 468
Jonathan Calkwood United States 8 308 0.5× 132 0.4× 142 0.5× 91 0.4× 98 0.7× 15 415
Lana Zhovtis Ryerson United States 12 374 0.6× 188 0.6× 121 0.4× 181 0.9× 86 0.6× 36 509
Juha-Pekka Erälinna Finland 14 406 0.7× 161 0.5× 59 0.2× 154 0.7× 196 1.4× 24 748
Augusto Miravalle United States 10 412 0.7× 155 0.5× 41 0.1× 208 1.0× 132 0.9× 28 629
Claes Martin Sweden 12 260 0.4× 100 0.3× 139 0.4× 303 1.5× 251 1.7× 15 888
Karen O’Connell Ireland 13 231 0.4× 106 0.3× 140 0.4× 53 0.3× 136 0.9× 29 683
Corinne Brunet France 13 164 0.3× 126 0.4× 113 0.4× 88 0.4× 284 2.0× 21 683
N. König Germany 10 187 0.3× 53 0.2× 102 0.3× 145 0.7× 416 2.9× 18 796

Countries citing papers authored by Cinzia Cordioli

Since Specialization
Citations

This map shows the geographic impact of Cinzia Cordioli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cinzia Cordioli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cinzia Cordioli more than expected).

Fields of papers citing papers by Cinzia Cordioli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cinzia Cordioli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cinzia Cordioli. The network helps show where Cinzia Cordioli may publish in the future.

Co-authorship network of co-authors of Cinzia Cordioli

This figure shows the co-authorship network connecting the top 25 collaborators of Cinzia Cordioli. A scholar is included among the top collaborators of Cinzia Cordioli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cinzia Cordioli. Cinzia Cordioli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Tumani, Hayrettin, Patricia K. Coyle, Claudia Cárcamo, et al.. (2023). Treatment of older patients with multiple sclerosis: Results of an International Delphi Survey. Multiple Sclerosis Journal - Experimental Translational and Clinical. 9(3). 3100561788–3100561788. 4 indexed citations
3.
Battaglia, Mario Alberto, Daiana Bezzini, Cinzia Cordioli, et al.. (2022). Patients with multiple sclerosis: a burden and cost of illness study. Journal of Neurology. 269(9). 5127–5135. 23 indexed citations
4.
Immovilli, Paolo, Irene Schiavetti, Cinzia Cordioli, et al.. (2022). Lung involvement correlates with disability in MS patients with COVID-19 pneumonia. Neurological Sciences. 43(12). 6657–6659. 1 indexed citations
5.
Sormani, Maria Pia, Nicola De Rossi, Irene Schiavetti, et al.. (2021). Disease‐Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis. Annals of Neurology. 89(4). 780–789. 296 indexed citations breakdown →
6.
Sormani, Maria Pia, Nicola De Rossi, Irene Schiavetti, et al.. (2021). Different disease modifying therapies can increase or decrease Covid-19 severity in Multiple Sclerosis (2021). Neurology. 96(15_supplement). 4 indexed citations
7.
Cordioli, Cinzia, Graziella Callari, Roberta Fantozzi, et al.. (2021). Pegylated interferon beta-1a (Plegridy) Italian real-world experience: a Delphi analysis of injection-site reaction and flu-like symptom management. Neurological Sciences. 42(4). 1515–1521. 2 indexed citations
8.
Prosperini, Luca, Chiara Mancinelli, Claudio Solaro, et al.. (2020). Induction Versus Escalation in Multiple Sclerosis: A 10-Year Real World Study. Neurotherapeutics. 17(3). 994–1004. 39 indexed citations
9.
Cutter, Gary, Alexey Boyко, Maria Zakharova, et al.. (2020). Satisfaction and adherence with glatiramer acetate 40mg/mL TIW in RRMS after 12 months, and the effect of switching from 20mg/mL QD. Multiple Sclerosis and Related Disorders. 40. 101957–101957. 6 indexed citations
10.
Rossi, Nicola De, Cristina Scarpazza, Chiara Filippini, et al.. (2020). Early use of low dose tocilizumab in patients with COVID-19: A retrospective cohort study with a complete follow-up. EClinicalMedicine. 25. 100459–100459. 68 indexed citations
11.
Prosperini, Luca, Chiara Mancinelli, Shalom Haggiag, et al.. (2020). Minimal evidence of disease activity (MEDA) in relapsing-remitting multiple sclerosis. Journal of Neurology Neurosurgery & Psychiatry. 91(3). 271–277. 32 indexed citations
12.
Cutter, Gary, Alexey Boyко, Maria Zakharova, et al.. (2019). Higher satisfaction and adherence with glatiramer acetate 40 mg/mL TIW vs 20 mg/mL QD in RRMS. Multiple Sclerosis and Related Disorders. 33. 13–21. 13 indexed citations
13.
Frau, Jessica, Maria Pia Sormani, Alessio Signori, et al.. (2018). Clinical activity after fingolimod cessation: disease reactivation or rebound?. European Journal of Neurology. 25(10). 1270–1275. 48 indexed citations
14.
Prosperini, Luca, Cristina Scarpazza, Luisa Imberti, et al.. (2017). Age as a risk factor for early onset of natalizumab-related progressive multifocal leukoencephalopathy. Journal of NeuroVirology. 23(5). 742–749. 30 indexed citations
15.
Cordioli, Cinzia, Nicola De Rossi, Sarah Rasia, Giuseppe Santuccio, & Ruggero Capra. (2016). Rituximab Treatment of Highly Active Multiple Sclerosis (MS) After Natalizumab-Related Progressive Multifocal Leukoencephalopathy (PML) (P6.166). Neurology. 86(16_supplement). 2 indexed citations
16.
Prosperini, Luca, Francesco Saccà, Cinzia Cordioli, et al.. (2016). Real-world effectiveness of natalizumab and fingolimod compared with self-injectable drugs in non-responders and in treatment-naïve patients with multiple sclerosis. Journal of Neurology. 264(2). 284–294. 41 indexed citations
17.
18.
Serana, Federico, Luisa Imberti, Maria Pia Amato, et al.. (2014). MxA mRNA Quantification and Disability Progression in Interferon Beta-Treated Multiple Sclerosis Patients. PLoS ONE. 9(4). e94794–e94794. 15 indexed citations
19.
Chiarini, Marco, Alessandra Sottini, Claudia Ghidini, et al.. (2009). Renewal of the T-cell compartment in multiple sclerosis patients treated with glatiramer acetate. Multiple Sclerosis Journal. 16(2). 218–227. 18 indexed citations
20.
Serana, Federico, Alessandra Sottini, Claudia Ghidini, et al.. (2008). Modulation of IFNAR1 mRNA expression in multiple sclerosis patients. Journal of Neuroimmunology. 197(1). 54–62. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alexander Winkelmann Breakdown of academic impact, for papers by Zoé L. E. van Kempen Breakdown of academic impact, for papers by Jonathan Calkwood Breakdown of academic impact, for papers by Lana Zhovtis Ryerson Breakdown of academic impact, for papers by Juha-Pekka Erälinna Breakdown of academic impact, for papers by Augusto Miravalle Breakdown of academic impact, for papers by Claes Martin Breakdown of academic impact, for papers by Karen O’Connell Breakdown of academic impact, for papers by Corinne Brunet Breakdown of academic impact, for papers by N. König
Rankless by CCL
2026